Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia

scientific article published on April 2010

Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1749-6632.2009.05299.X
P698PubMed publication ID20398021

P50authorGiuseppe PennaQ55437737
Mario MaggiQ67191115
P2093author name stringLuciano Adorini
Benedetta Fibbi
P2860cites workPre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol).Q36587375
Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathwaysQ40671067
Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitolQ42505016
P407language of work or nameEnglishQ1860
P921main subjectvitamin DQ175621
inflammationQ101991
vitaminQ34956
P304page(s)146-152
P577publication date2010-04-01
P1433published inAnnals of the New York Academy of SciencesQ2431664
P1476titleVitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia
P478volume1193